The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 55 | — | 20.1x | Near average | |
Growth | 12 | -100.0% | 5.6% | Below average | |
Quality | 12 | -82.5% | 7.6% | Below average | |
Safety | 66 | 1.3x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Xenon Pharmaceuticals Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Xenon Pharmaceuticals Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
XENE stock shows remarkable stability in analyst estimates over the past 30 days, with the average price target stabilizing at 85 dollars based on a consensus of 13 analysts. Despite the significant gap between the low (60 dollars) and high (100 dollars), the current price (54.17 dollars) is trading below the lowest forecast, indicating general institutional optimism for a potential rebound, especially with a Median price of 89.5 dollars, which is higher than the overall average.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.